Core Viewpoint - The case highlights the importance of clear and effective inquiry by insurance companies regarding the "duty of disclosure" by policyholders, particularly in the context of family medical history and genetic diseases [1][4][8]. Group 1: Case Background - A 90s-born woman, Ms. Huang, faced denial of her critical illness insurance claim due to alleged non-disclosure of her family's cancer history [1][3]. - The insurance company claimed that Ms. Huang's mother had breast and ovarian cancer, and her grandmother had lung cancer, suggesting she was aware of her hereditary risk [3][4]. - Ms. Huang argued that she had disclosed her family medical history to the sales representative and that the insurer did not make a clear inquiry about the "family tumor history" [3][4]. Group 2: Court Rulings - The first-instance court ruled that the insurance company failed to make an effective inquiry regarding the "family tumor history," thus Ms. Huang did not violate her duty of disclosure [3][4]. - The Beijing Financial Court upheld this ruling, stating that the inquiry about "hereditary diseases" did not equate to a clear question about "family tumor history" [6][8]. - The court emphasized that the insurer's inquiry must be clear and specific, and the lack of such inquiry means the policyholder is not obligated to disclose information that was not explicitly asked for [6][8]. Group 3: Legal Implications - The case underscores that nearly 70% of personal insurance disputes involve the recognition of the duty of disclosure, which significantly impacts both insurers and insured parties [8]. - The ruling serves as a precedent for guiding insurance companies to standardize their inquiry processes and ensure consumer protection in the insurance industry [8].